Inventor · disambiguated record
Nobutaka Ninomiya
Also filed as: NINOMIYA NOBUTAKA
11 granted patents·2 pending applications·123 citations·filing 1999–2014
90Inventor score
Top patents by PatentIndex Score
13 records- 0187US7732492B2Nateglinide-containing preparationAJINOMOTO KK·Filed 2006·Granted Jun 8, 2010·14 cites·15 claims
- 0285US6844008B2Tablet compositionAJINOMOTO KK·Filed 2003·Granted Jan 18, 2005·16 cites·17 claims
- 0385US6830759B2Antidiabetic preparation for oral administrationAJINOMOTO KK·Filed 2002·Granted Dec 14, 2004·25 cites·92 claims
- 0483US6296872B1Tablet composition of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanineAJINOMOTO KK·Filed 2000·Granted Oct 2, 2001·12 cites·5 claims
- 0581US6641841B2Tablet compositionAJINOMOTO KK·Filed 2001·Granted Nov 4, 2003·10 cites·6 claims
- 0675US6143323ATablet compositionAJINOMOTO KK·Filed 1999·Granted Nov 7, 2000·32 cites·11 claims
- 0774US7488498B2Antidiabetic preparation for oral administrationAJINOMOTO KK·Filed 2005·Granted Feb 10, 2009·2 cites·57 claims
- 0873US7605180B2Nateglinide-containing preparationAJINOMOTO KK·Filed 2003·Granted Oct 20, 2009·6 cites·20 claims
- 0971US7022339B2Antidiabetic preparation for oral administrationAJINOMOTO KK·Filed 2002·Granted Apr 4, 2006·6 cites·52 claims
- 1058US2009203791A1Nateglinide-containing preparationAJINOMOTO KK·Filed 2009·Application pending·0 cites
- 1155US9339483B2Amino-acid-containing medicinal granular preparation highly easy to takeAJINOMOTO KK·Filed 2014·Granted May 17, 2016·0 cites·9 claims
- 1251US2004029968A1Nateglinide-containing hydrophilic pharmaceutical preparationAJINOMOTO KK·Filed 2003·Application pending·0 cites
- 1337US9301937B2Amino-acid-containing medicinal granular preparation highly easy to takeIDA MITSUYASU·Filed 2010·Granted Apr 5, 2016·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Nobutaka Ninomiya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →